6 news items
Vaxart Announces $40 Million Underwritten Offering of Common Stock
VXRT
13 Jun 24
without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT
13 Jun 24
to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VXRT
23 May 24
and to eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
VXRT
13 May 24
without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
VXRT
27 Mar 24
to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes
l4linf1swreq5fqm7blqfdjqj3aw13nedckt8f
VXRT
20 Mar 24
of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning
- Prev
- 1
- Next